Gene · 5745
Papers2,698
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,698
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unveiling the power of microenvironment in liver regeneration: an in-depth overview. | Front Genet | 2023 | 38152656 | PubTator, text mining | PubMed |
| Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus. | Front Immunol | 2023 | 38146370 | PubTator, text mining | PubMed |
| Osteobiologies for Spinal Fusion from Biological Mechanisms to Clinical Applications: A Narrative Review. | Int J Mol Sci | 2023 | 38139194 | PubTator, text mining | PubMed |
| A Novel Heterozygous Mutation c.1627G>T (p.Gly543Cys) in the SLC34A1 Gene in a Male Patient with Recurrent Nephrolithiasis and Early Onset Osteopenia: A Case Report. | Int J Mol Sci | 2023 | 38139117 | PubTator, text mining | PubMed |
| Stem Cells Derived from Human Exfoliated Deciduous Teeth Functional Assessment: Exploring the Changes of Free Fatty Acids Composition during Cultivation. | Int J Mol Sci | 2023 | 38139076 | PubTator, text mining | PubMed |
| Methods for Engineering Binders to Multi-Pass Membrane Proteins. | Bioengineering (Basel) | 2023 | 38135942 | PubTator, text mining | PubMed |
| New Human Leukocyte Antigen (HLA) Antibody Formation and Creatinine Elevation With Abaloparatide in Kidney Transplant Recipient. | JBMR Plus | 2023 | 38130769 | PubTator, text mining | PubMed |
| Transitory Activation and Improved Transition from Erosion to Formation within Intracortical Bone Remodeling in Hypoparathyroid Patients Treated with rhPTH(1-84). | JBMR Plus | 2023 | 38130746 | PubTator, text mining | PubMed |
| Potential application of anti-osteoporotic therapy to relieve sarcopenia in the elderly. | Ann Med Surg (Lond) | 2023 | 38098566 | PubTator, text mining | PubMed |
| The effects of semaphorin 3A in bone and cartilage metabolism: fundamental mechanism and clinical potential. | Front Cell Dev Biol | 2023 | 38078001 | PubTator, text mining | PubMed |
| Progress in Prevention and Treatment of Acute Bone Loss in Orthopedics. | Int J Endocrinol | 2023 | 38077930 | PubTator, text mining | PubMed |
| Fluoxetine treatment during the postpartal period may have short-term impacts on murine maternal skeletal physiology. | Front Pharmacol | 2023 | 38074149 | PubTator, text mining | PubMed |
| Tear Fluid Inflammatory Proteome Analysis Highlights Similarities Between Keratoconus and Allergic Conjunctivitis. | Invest Ophthalmol Vis Sci | 2023 | 38064228 | PubTator, text mining | PubMed |
| Identification of key genes and pathways in adrenocortical carcinoma: evidence from bioinformatic analysis. | Front Endocrinol (Lausanne) | 2023 | 38053725 | PubTator, text mining | PubMed |
| Structure, function and drug discovery of GPCR signaling. | Mol Biomed | 2023 | 38047990 | PubTator, text mining | PubMed |
| Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study. | Front Med (Lausanne) | 2023 | 38034538 | PubTator, text mining | PubMed |
| Renal complications in chronic hypoparathyroidism - a systematic cross-sectional assessment. | Front Endocrinol (Lausanne) | 2023 | 38027217 | PubTator, text mining | PubMed |
| Combined signature of G protein-coupled receptors and tumor microenvironment provides a prognostic and therapeutic biomarker for skin cutaneous melanoma. | J Cancer Res Clin Oncol | 2023 | 38006451 | PubTator, text mining | PubMed |
| The FDA's New Guideline "Generally Accepted Scientific Knowledge" (GASK): An Opportunity to Expedite the Approval of Biosimilars. | Pharmaceuticals (Basel) | 2023 | 38004383 | PubTator, text mining | PubMed |
| Anterior Open Bite Malocclusion: From Clinical Treatment Strategies towards the Dissection of the Genetic Bases of the Disease Using Human and Collaborative Cross Mice Cohorts. | J Pers Med | 2023 | 38003932 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5745/papers?page=10